Personal PCR results, when and where you need them


Our single-use test delivers a fast and accurate result right at the point of need.

Personal PCR —
everything you need in one box

One device equals one result.

Product
Features

Our test is easy to use, accurate and provides quick results.


  • A

    Status Lights

    LED lights tell you the test is running and alerts you when completed.

  • B

    Input Sample

    Dispense the sample into the open port and slide button 1 closed.

  • C

    End-to-End PCR

    By putting the power of the lab in the palm of your hand, we make PCR portable.

  • D

    Test Control

    A defined spot next to “Results Valid” confirms the test control.

  • E

    Test Results

    In less than 30 minutes, a spot appears if the test result is positive.

Group 102Created with Sketch.

“With our device you get the results you need while you’re still face to face with the patient, helping you make better and more timely decisions.”

Dr. Gary Schoolnik
Chief Medical Officer, Visby Medical

Become our Partner

Personal PCR changes the way we think about diagnostics. We’re looking for partners to deploy Personal PCR and make a difference — not only in the fight against COVID-19, but also against serious infection everywhere.

Learn More

Learn to use the Visby Personal PCR

Less than 2 minutes of hands-on time. Results in less than 30 minutes.

Using the test

We made Personal PCR with the potential to be used by anyone, anywhere. Below are resources to help run a successful test.

Visby Medical COVID-19 test has not been FDA cleared or approved; it has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The Visby Medical COVID-19 test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.